Chemicals Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Chemicals Press Releases.

Press releases published on June 22, 2026

Jun. 22, 2026

Next-Generation DNA Repair Therapies Open New Frontiers in Oncology

Indeterminate GlobeNewswire

Jun. 22, 2026

Independent Fire Testing Confirms Eos Z3 Battery System Exhibited No Thermal Runaway, No Sustained Fire, and No Propagation Under Abuse Testing; Company Receives ISO 14001 Certification

Indeterminate GlobeNewswire

Jun. 22, 2026

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

Indeterminate GlobeNewswire

Jun. 22, 2026

FibroBiologics Receives Notice of Allowance for U.S. Patent Covering Topical Fibroblast Spheroid Therapy for Wound Healing

Indeterminate GlobeNewswire

Jun. 22, 2026

Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis

Indeterminate GlobeNewswire

Jun. 22, 2026

NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization

Indeterminate GlobeNewswire

Jun. 22, 2026

Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity

Indeterminate GlobeNewswire

Jun. 22, 2026

CaoCao Announces Full-Scale AI Transformation, Unveils RoboX Strategy to Build a Globally Leading Physical AI Mobility Technology Platform

Indeterminate GlobeNewswire

Jun. 22, 2026

Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery

Indeterminate GlobeNewswire

Jun. 22, 2026

Defence Construction Canada to hold 2026 Annual Public Meeting

Indeterminate GlobeNewswire

Jun. 22, 2026

Construction de Défense Canada organise l’édition 2026 de l’Assemblée publique annuelle

Indeterminate GlobeNewswire

Jun. 22, 2026

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Indeterminate GlobeNewswire

Jun. 22, 2026

Take 5 Oil Change Opens New Location in Colorado Springs

Indeterminate GlobeNewswire

Jun. 22, 2026

Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts 

Indeterminate GlobeNewswire

Jun. 22, 2026

Outdoor Holding Company Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire

Jun. 22, 2026

Xeriant Sets Up Next Production Run of NEXBOARD™ Following Class A Fire Rating and NFPA 286 Fire Testing Certification

Indeterminate GlobeNewswire

Jun. 22, 2026

ASML reports transactions under its current share buyback program

Indeterminate GlobeNewswire

Jun. 22, 2026

Tyson® Debuts New Garlic & Herb, BBQ, and Harissa Chicken Cups

Indeterminate GlobeNewswire

Jun. 22, 2026

Novel Key Terms For Managing CIDP Published in Neurology® Journal

Indeterminate GlobeNewswire

Jun. 22, 2026

Refinity Secures Exclusive License to PNNL Catalyst Technology to Convert Olefins into Circular Hydrocarbon Liquids for SAF Production

Indeterminate GlobeNewswire